Cases & Deals

Pharmaceutical and device manufacturers advised on Physician Payments Sunshine Act

Clients Pharmaceutical and device manufacturers

Jones Day has been advising several pharmaceutical and device manufacturers on the reporting of payments or other transfers of value under the Physician Payments Sunshine Act, including analysis of specific scenarios involving subsidiaries, foreign and domestic, co-development arrangements, research activities, licensing and material transfer arrangements, and other payments or transfers of value related to covered recipients.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.